What is recombinant human interferon α2b suppository?
Under normal circumstances, recombinant human interferon α2b suppositories are a type of interferon medication and should be used strictly according to medical instructions. The detailed analysis is as follows:

The main active ingredient in recombinant human interferon α2b suppositories is recombinant human interferon α2b, a protein that exhibits antiviral effects and inhibits cell proliferation. By binding to interferon receptors on the surface of target cells, recombinant human interferon α2b induces cells to produce antiviral proteins, blocks viral protein synthesis, and suppresses replication and transcription of viral nucleic acids, thereby exerting its antiviral effects.
At the same time, it enhances the phagocytic activity of macrophages and promotes the body's immune defense function. Recombinant human interferon α2b suppositories are primarily used to treat chronic cervicitis, cervical erosion, vaginitis, and other conditions caused by viral infections of the vagina. Additionally, they can be used for cervical cancer prevention and as an adjunctive treatment for viral infections such as viral hepatitis and genital warts.
Children and pregnant women should use recombinant human interferon α2b suppositories with caution, and individuals with hypersensitivity should use them carefully. It is recommended to use this medication only under the guidance of a physician. Self-administration should be avoided to prevent possible transient adverse reactions such as low-grade fever, lower abdominal pain, or backache.